ORX489

· Centessa Pharmaceuticals (UK) Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ORX489, covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years [Phase 1]